Basal cell carcinoma (BCC) is the most common type of skin cancer worldwide, often producing shiny lesions on the skin that can be (but are not always) discolored. It develops in the basal cells ...

Thirteen patients (eight females, five males) in the age range 41-76 years (median 57.7 ± 3.63 years) with a total of 20 BCC lesions (ten patients had one each, two patients had two and one ...

The other skin changes in the healing sites were slight ... No patients developed BCC lesions at other sites distant from the IFN-treated areas during the follow-up period.

Basal cell carcinoma (BCC) is the most common type of skin cancer, arising from the basal cells located in the epidermis, the ...

The potency of AIV001 and prolonged drug release in the skin provided clinical and histological clearance of biopsied-confirmed BCC lesions in 26 patients. In addition, a total of 41 subjects were ...

GlobeNewswire, Pharmaceuticals & Biotechnology, Product / Services Announcement | AIV001 is currently in development for evaluation in Superfi ...